Financhill
Back

Oracle Corp. Vs. Novo Nordisk A/S Industry Stock Comparison

Sell
37

ORCL
Oracle Corp.

Last Price:
$217.57
Seasonality Move:
12.46%
Sell
27

NVO
Novo Nordisk A/S

Last Price:
$47.92
Seasonality Move:
5.86%
Sell
37
Oracle Corp. (ORCL) is a Sell

Is Oracle Corp. a Buy, Sell or Hold?

  • The current Oracle Corp. [ORCL] share price is $217.58. The Score for ORCL is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • ORCL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Novo Nordisk A/S (NVO) is a Sell

Is Novo Nordisk A/S a Buy, Sell or Hold?

  • The current Novo Nordisk A/S [NVO] share price is $47.86. The Score for NVO is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ORCL Stock Price Chart

What is Oracle Corp.'s stock price today?

  • The Oracle Corp. share price today is $217.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ORCL is experiencing slight buying pressure.

NVO Stock Price Chart

What is Novo Nordisk A/S's stock price today?

  • The Novo Nordisk A/S share price today is $47.86
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.

ORCL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -13.22 Sell
Relative Strength Index (14 RSI): 44.28 Sell
Chaikin Money Flow: 8398932 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (203.29 - 242.11) Sell
Bollinger Bands (100): (223.5 - 288.94) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.97 Sell
Relative Strength Index (14 RSI): 45.11 Sell
Chaikin Money Flow: -14612448 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.75 - 49.23) Sell
Bollinger Bands (100): (48.28 - 60.02) Sell

ORCL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 205.7 Buy
20-day SMA: 215.24 Buy
50-day SMA: 254.62 Sell
200-day SMA: 211.87 Buy
8-day EMA: 209.8 Buy
20-day EMA: 218.9 Sell
50-day EMA: 239.33 Sell
200-day EMA: 222.51 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.05 Sell
20-day SMA: 47.9 Sell
50-day SMA: 51.91 Sell
200-day SMA: 62.92 Sell
8-day EMA: 47.9 Sell
20-day EMA: 48.45 Sell
50-day EMA: 51.04 Sell
200-day EMA: 64.63 Sell

Oracle Corp. Earnings Growth & ORCL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $0.82 per share.

Novo Nordisk A/S Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and a decrease next year of $0.10 per share.

Oracle Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk A/S Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):